SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-001848
Filing Date
2024-01-09
Accepted
2024-01-09 17:01:41
Documents
13
Period of Report
2023-12-21
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 45386
  Complete submission text file 0001493152-24-001848.txt   275106

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20231221.xsd EX-101.SCH 3976
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20231221_def.xml EX-101.DEF 27432
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20231221_lab.xml EX-101.LAB 37886
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20231221_pre.xml EX-101.PRE 26049
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6337
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40943 | Film No.: 24523970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)